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Objectives: To investigate the genetic polymorphisms of rs1008949 and rs1996147 of
EGR3 gene in healthy Chinese Han and Uygur population of Xinjiang.
Methods: The genotypes of the EGR3 gene were detected in 303 Uygur and 351 Han
healthy individuals using the TaqMan SNP genotyping assay.
Results: The genotype distributions of both populations were in the Hardy-Weinberg
equilibrium (P>0.05). The frequencies of CC,CT and TT genotypes of the rs1008949
locus were 34.3%,50.2%,and 15.5% in the Uygurs, and 28.2%,49.3%and 22.5% in the
Han participants. There was signiﬁcant difference in distribution of genotypes be-
tween the two populations (P<0.001). The frequencies of AA, AG and GG genotypes
of the rs1996147 locus were 24.7%, 51.5%, and 23.8% in Uygur participants, and
14.0%, 44.4%and 41.6%in Han participants. There was also signiﬁcant difference in
distribution of genotypes between the two populations (P<0.001).
Conclusions: The mutational frequencies of the tagging SNPs in rs1008949 and
rs1996147 loci of the EGR3 gene were signiﬁcantly different between Uygur and Han
populations.
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Evaluation anti-atrial ﬁbrillation drug model of multi-ion channels as a target
with micro-electrode chip technology
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Objectives: To screen and evaluate effection of anti-atrial ﬁbrillation drug on rapid
atrial pacin rabbit model with microelectrode arrays (MEA).
Methods: 32 rabbits were randomely divided into 4 groups: TEA group (n¼8), BaCl2
group (n ¼8), CdCl2 group (n ¼8), Amiodarone group (n¼8). The electrode was
inserted into right atrium via internal jugular vein with rapid right atrial pacing
(600 beat/min). effection of anti-atrial ﬁbrillation drug on ion channels were observed
after giving drugs (TEA, BaCl2, CdCl2 and Amiodarone).
Results: ﬁeld action potential (fAPD) prolonged in TEA group and BaCl2 group
(control vs blocker: 176.678.66 ms vs 196.1110.76 ms, 182.2212.87 ms vs
191.1113.09 ms, respectively, P<0.05). fAPD prolonged in CdCl2 group (control vs
blocker: 176.678.66ms vs 196.1110.76ms) (P<0.05). fAPD obviously extended
in Amiodarone group (control vs Amiodarone: 167.3813.67ms 18515.14ms,
P<0.01).
Conclusions: Atrial ﬁbrillation induced by rapid atrial pacing is a stable and reliable
Anti-arrhythmic drug therapy for atrial ﬁbrillation screening model on rabbit, It can be
used for anti-atrial ﬁbrillation drug development at early the rapid screening combines
with microelectrode chip technology.
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Objectives: Intercellular adhesion molecule-1 is an important adhesion molecule that
plays a crucial role in lymphocyte migration and in atherosclerosis pathogenesis
activation. The aim of the present study was to explore the association between the
rs5498 polymorphism of the ICAM-1 Gene and coronary heart disease (CHD) in Han
population in Xinjiang, China.
Methods: rs5498 polymorphism of ICAM-1 gene was detected with method of
polymerase chain reaction-restricted fragments length polymorphism in 674 CHD
patients and 779 control subjects.
Results: For total, the frequency of G allele was signiﬁcantly higher in CHD
patients than that in controls (29.2% vs. 23.3%, P<0.001). The frequency of
AG+GG genotypes was higher in patients with CHD than that in controls (49.7%
vs. 40.8%, P¼0.001). Multiple logistic regression analysis showed AG+GG was an
independent risk factor for CHD (OR¼1.919, 95%CI: 1.471-2.503, P<0.001). For
men, the frequencies of G allele and AG+GG genotype were also higher in CHD
patients than those in control subjects (29.9% vs. 22.7%, P<0.001 for frequency of
G allele; 50.6% vs. 40.3%, P¼0.001 for AG+GG genotype). For women, we didn’t
observe any signiﬁcant difference in genotype or allele distribution between the two
groups.
Conclusions: In the present study, rs5498 polymorphism of ICAM-1 gene was
associated with CHD in men of Chinese Han population. Men with G allele (AG and
GG genotype) might have higher risk for CHD than those with AA genotype.C24 JACC Vol 64/16/Suppl C j OctobGW25-e3503
OSM induced cardiomyocyte dedifferentiation regulates the progression of
diabetic cardiomyopathy through B-Raf/MeK/Erk signaling pathway
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Objectives: It has been reported that oncostatin M (OSM) could initiate car-
diomyocyte dedifferentiation both in vivo and in vitro. OSM-induced cardiomyocyte
dedifferentiation might be a new target for the treatment of diabetic cardiomyopathy
(DCM). This study was designed to determine the role of OSM in cardiomyocyte
dedifferentiation and the progression of DCM.
Methods: Mouse DCM model were established to evaluate the effects of OSM in vivo
by injection of STZ for 5 consecutive days and random blood glucose value of
 16.7mmol/L was considered as a cutoff point for diabetes. Transthoracic echocar-
diography was applied to determine cardiac function. Immunoﬂuorescence staining
was used to detected dedifferentiation markers such as Runx1 and ANP. Sirus red
staining was used to detect ﬁbrosis area and Transmission electron microscopy (TEM)
was used to evaluate mitochondria impairment. Real Time PCR and Western blot were
performed to detect relative mRNA expression and the expressions of cardiomyocytes
dedifferentiation related proteins such as c-kit, scal-1, a-SM-actin, Runx1 and ANP.
Results: DCM mice exhibited multiple functional and structural changes in car-
diomyocytes and OSM treatment induced similar biological changes as those detected
in DCM mice. LVEF (49.253.75% vs. 70.074.37%, P<0.05) and FS (28.20
3.30% vs. 38.025.66%, P<0.05) were decreased, while LVEDV (87.187.47mL
vs. 75.508.23mL, P<0.05) and LVESV (40.092.99mL vs. 22.154.32mL, P<0.05)
were increased by OSM treatment as compared with the saline treated group. OSM
administration increased cardiac ﬁbrosis area (4.030.53% vs. 1.110.44%, P<0.05)
and aggravated mitochondria impairment as compared with control mice. Immuno-
ﬂuorescence staining showed OSM administration also signiﬁcantly up-regulated the
expressions of dedifferentiation makers Runx1 and ANP. Real-time PCR detected the
mRNA expression of OSM, Ob, c-kit, Runx1 and ANP were increased in OSM treated
mice compared with control mice and Western blot revealed the protein expression of
dedifferentiation makers (Runx1, a-SM-actin and ANP), typical fetal genes (c-kit, scal-
1) were increased in OSM treated mice compared with control mice. OSM recepror Ob
KO mice were used and B-Raf, Mek, P-Erk and total-Erk expressions were detected by
Western blot, indicating the mechanism of OSM induced cardiomyocyte dedifferen-
tiation was associated with B-Raf/Mek/Erk signaling pathway through Ob receptor.
Conclusions: We provided direct evidence that OSM played a crucial role in the
progression of diabetic cardiomyopathy through inducing cardiomyocyte dedifferen-
tiation. The mechanism of OSM induced cardiomyocyte dedifferentiation was asso-
ciated, at least in part, with B-Raf/Mek/Erk signaling pathway. The ﬁndings of the
present study might provide a new therapeutic molecular target for the further treat-
ment of diabetic cardiomyopathy.
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Resveratrol Alleviates Diabetic Cardiomyopathy through Improvement of
Mitochondrial Biogenesis and Function in a SIRT1-dependent Manner
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Objectives: Diabetic cardiomyopath (DCM) is associated with impaired mitochon-
drial biogenesis and function. Resveratrol, an activator of SIRT1, has been reported to
increase mitochondrial mass. Our study was designed to investigate whether resver-
atrol is capable of protecting against DCM via mitochondrial regulation.
Methods: Cardiac-speciﬁc SIRT1 KO mice (SIRT1CKO) were generated with SIRT1-
ﬂoxp+/+ and Myh6-Cre transgenic mice. Mice model were divided into six groups:
control group, DCM group, DCM+ Resveratrol group (DCM+ RES), SIRT1CKO
group, SIRT1CKO+ DCM group (SIRT1CKO+ DCM) and SIRT1CKO+ DCM+
Resveratrol group (SIRT1CKO+ DCM +R). DCM mice were injected with strepto-
zotoin. Resveratrol was added at the dose of 25 mg/kg/day for two months. Echo-
cardiography, HE, Masson trichrome, Sirus red staining and transmission electron
microscope were applied to reveal heart function, remodeling and mitochondrial
morphology. Cardiomyocyte apoptosis was assessed with TUNEL. In vitro H9c2 cell
study included six groups: control group, high glucose treated group (HG), HG+
Resveratrol group (HG+ RES), sh-SIRT1 group, sh-SIRT1+ HG group (sh-SIRT1+
HG) and sh-SIRT1+ HG+ Resveratrol group (sh-SIRT1+ HG+ R). Mitochondrial
function was evaluated by ATP generation, membrane potential (TFRM ﬂuorescence)
and citrate synthase activity. Mitochondrial biogenesis was analyzed with mtDNA
copy number. Immunoprecipitation was done to reveal the acetylation of SIRT1 tar-
geted PGC-1a. mRNA and protein expression of PGC-1a downstream genes (NRF-1,
NRF-2, ERR-a and TFAM) were analyzed with Real-time PCR and Western blot.
Results: SIRT1 expression was nearly undetectable in heart tissue of SIRT1CKO. As
compared with WT mice, DCM mice showed reduced cardiac function, damaged
cardiac ultrastructure and remodeling, accompanied with increased cardiomyocyte
apoptosis, decreased ATP generation and mtDNA amount (P<0.05), indicating
impaired mitochondrial function and biogenesis. DCM mice showed reduced SIRT1
expression in heart tissue. Resveratrol reversed these changes in DCM mice, but not in
DCM+ SIRT1CKO mice. In vitro results revealed that HG increased cell apoptosis as
compared with control group (P<0.05). Moreover, HG reduced mitochondrial
biogenesis and function in cardiomyocytes, evidenced by decreased ATP generation,er 16–19, 2014 j GW-ICC Abstracts/Basic and Translational Medicine
